Brainsway (BWAY) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.05
- Estimate
- $0.09
- Surprise
- -42.3%
- Score today
- 6.6/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Brainsway (BWAY) missed the $0.09 estimate with adjusted EPS of $0.05 — a large 42.3% shortfall.
Coverage in the report window
- BrainsWay Q3 EPS $0.05 Misses $0.09 Estimate, Sales $18.146M Beat $17.891M Estimate — benzinga, 2026-11-10
Where TrendMatrix's rating stands now
TrendMatrix currently rates BWAY Hold at 6.6/10; no pre/post engine snapshot brackets this report.
1 of the last 4 quarters beat the estimate; this quarter's -42.3% surprise compares with a +32.1% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong growth profile
What argues against it
- Momentum score 4.0/10 — below 4.5 minimum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $10.67
- Price target
- $16.38
- Stop
- $9.92
- Upside to target
- +53.5%
- Reward-to-risk
- 4.4:1
The stock trades at 46.4× trailing but 21.1× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: trading volume is running 4.5× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-11 — shown for context, not personalized investment advice.
BWAY at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $429.5M
- P/E (fwd)
- 21.1
- P/E (ttm)
- 46.4
- 52-week range
- $7.13–$17.40
- Off 52-week high
- 38.7%
- RSI (14)
- 38
- Volume vs avg
- 4.54×
- Score today
- 6.6/10